ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Lower cardiac output is a risk factor for faster cerebral atrophy over a 11-year follow-up period in APOE-ε4 carriers.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionSubclinical lower cardiac output (volume of blood pumped per minute) cross-sectionally relates to smaller cerebral gray matter volumes in older adults. This study relates cardiac output to longitudinal gray matter volumes among middle-aged and older adults over an 11-year period.
methodsLinear regression (cross-sectional) and mixed effects (longitudinal) models related baseline cardiac output to gray matter volume trajectory, adjusting for demographic factors. Secondary models tested cardiac output × apolipoprotein E (APOE) -ε4 status interactions.
resultsLower cardiac output related to smaller brain volumes (p-values < 0.04) in APOE-ε4 positive participants only. In longitudinal models, baseline cardiac output interacted with APOE-ε4 status (p = 0.006). Lower baseline cardiac output related to greater increase in inferior lateral ventricle volume over time in APOE-ε4 carriers (p = 0.01) only. DISCUSSION: Results suggest among APOE-ε4 carriers, subclinical cardiac dysfunction relates to greater neurodegeneration cross-sectionally and longitudinally. However, results must be interpreted with caution and replicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.